COVID-19 Archives - BioPharmaJournal

The U.S FDA Announces That Novavax, Inc. (NASDAQ: NVAX) is Effective...

Gavins Felicity - June 16, 2022 0

Sorrento Therapeutics Inc. (NASDAQ: SRNE) Releases Preliminary Phase 2 Abivertinib Study...

Kate Hudson - November 9, 2021 0

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Receives FDA Minutes On Pre-IND...

Gavins Felicity - September 2, 2021 0

Humanigen Inc (NASDAQ:HGEN) Demonstrates Improved Survival Of COVID-19 Patients In Phase...

Kate Hudson - May 4, 2021 0

Humanigen Inc. (NASDAQ:HGEN) Announce Encouraging Phase 3 Lenzilumab Study Results...

Kate Hudson - April 1, 2021 0

Vaxart Inc. (NASDAQ:VXRT) to Commence Phase Two Study Of Its Oral...

Kate Hudson - March 3, 2021 0

Amarin Corporation plc (NASDAQ:AMRN) Presents VASCEPA® Clinical Study Findings At The...

Matt Wade - February 3, 2021 0

Novavax Inc. (NASDAQ:NVAX) Enters COVID-19 Vaccine Supply Deals With the EU...

Ward Sport - January 27, 2021 0

Progenity Inc. (NASDAQ:PROG) Announces Expansion Of COVID-19 RT-PCR Test In The...

Kate Hudson - January 19, 2021 0

AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) Reports Study Progress of Ampligen Combination As...

Ward Sport - December 17, 2020 0

12 3...11 Page 1 of 11

Humanigen Inc. (NASDAQ: HGEN) Announces Strategic Realignment To Expedite Lenzilumab Development...

Kate Hudson - August 5, 2022 0

Humanigen Inc. (NASDAQ: HGEN) has announced the strategic realignment of its resources and pipeline in a bid to achieve its main clinical milestone. The...

IVERIC Bio Inc (NASDAQ: ISEE) Announces License Agreement With DelSiTech Ltd...

August 4, 2022

Biora Therapeutics Inc (NASDAQ: BIOR) Announces Topline Results From The Study...

August 3, 2022

Annexon Inc (NASDAQ: ANNX) Releases Encouraging Final Data Of ANX005 Study...

August 2, 2022

Exelixis Inc (NASDAQ: EXEL) Enters License Agreement With Ryvu Therapeutics S.A....

August 1, 2022

Tag: COVID-19

Recent Post